Newsletter September 2017 No.181
Top News
The "Kotto Policy 2017" was discussed.
On June 9, 2017, the Cabinet approved the "Basic Policies for Economic and Fiscal Management and Reform 2017" (the so-called "Keto-bata Policy 2017"). This paper outlines the areas that are expected to have a relatively large impact on the pharmaceutical industry, with a focus on the "Keto Daishi 2017".
Topics
Connecting with Citizens and Patients
Policy Research Institute
Production Trends of Biopharmaceuticals (Antibody Drugs) -Analysis of Sales Weight
From JPMA
Aiming to Contribute to "Extension of Healthy Life Expectancy